Mesoblast (MEOBF) Current Leases (2019 - 2026)
Mesoblast's (MEOBF) quarterly Current Leases came in at $5.1 million in Q2 2026, up 41.45% year-over-year from $3.6 million in Q2 2025, and down 13.99% quarter-over-quarter from $5.9 million in Q4 2025.
Analysis
Mesoblast (MEOBF) Current Leases (2019 - 2026) Analysis & Trends
Mesoblast has disclosed Current Leases across 8 years of filings, most recently posting $5.1 million for Q2 2026.
- In Q2 2026, Current Leases rose 41.45% year-over-year to $5.1 million; the TTM figure through Jun 2026 stood at $5.1 million (up 41.45% YoY), while the FY2026 annual figure was $5.1 million, up 41.45% from the prior year.
- Current Leases came in at $5.1 million for Q2 2026 at Mesoblast, down from $5.9 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $8.1 million in Q1 2022 to a low of $2.0 million in Q2 2024.
- Average Current Leases over 5 years is $5.0 million, with a median of $4.9 million recorded in 2022.
- Year-over-year, Current Leases slumped 48.17% in 2023 and surged 83.56% in 2025.
- Over 5 years, Current Leases stood at $5.0 million in 2022, then slumped by 32.28% to $3.4 million in 2023, then soared by 40.28% to $4.8 million in 2024, then advanced by 24.04% to $5.9 million in 2025, then declined by 13.99% to $5.1 million in 2026.
- Per Business Quant data, the three most recent Current Leases figures were $5.1 million in Q2 2026, $5.9 million in Q4 2025, and $3.6 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | 1.81 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | 18.65 Mn |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | 2.67 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | - |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 2.99 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | 15.21 Mn |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 1.06 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | - |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 14.16 Mn |
| 10 | Mesoblast | 246.02 Mn | 143.11 Mn | - | 5.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.07 Mn |
| Dec 31, 2025 | 5.89 Mn |
| Jun 30, 2025 | 3.58 Mn |
| Dec 31, 2024 | 4.75 Mn |
| Jun 30, 2024 | 1.95 Mn |
| Dec 31, 2023 | 3.39 Mn |
| Jun 30, 2023 | 3.67 Mn |
| Mar 31, 2023 | 4.65 Mn |
| Dec 31, 2022 | 5.00 Mn |
| Sep 30, 2022 | 6.35 Mn |
| Jun 30, 2022 | 7.09 Mn |
| Mar 31, 2022 | 8.05 Mn |
| Dec 31, 2021 | 7.94 Mn |
| Sep 30, 2021 | 7.56 Mn |
| Jun 30, 2021 | 8.49 Mn |
| Mar 31, 2021 | 6.48 Mn |
| Dec 31, 2020 | 6.51 Mn |
| Sep 30, 2020 | 7.05 Mn |
| Jun 30, 2020 | 6.32 Mn |
| Mar 31, 2020 | 5.76 Mn |